SPINEART Navigation Instrument System

K241644 · Spineart SA · OLO · Aug 7, 2024 · Neurology

Device Facts

• Record ID: K241644
• Device Name: SPINEART Navigation Instrument System
• Applicant: Spineart SA
• Product Code: OLO · Neurology
• Decision Date: Aug 7, 2024
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 882.4560
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Spineart Navigation Instrument System reusable instruments are intended to be used during the preparation and placement of Spineart screws during spinal surgery to assist the surgeon in precisely locating anatomical structures in either open or minimally invasive procedures. The Spineart Navigation Instrument System reusable instruments are specifically designed for use with the Medtronic StealthStation System, which is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as a long bone or vertebra, can be identified relative to a CT or MR based model, fluoroscopy images, or digitized landmarks for the anatomy.

Device Story

Reusable surgical instruments (screwdrivers, taps, drills) for spinal surgery; used with Medtronic StealthStation Navigation System and NavLock Tracker System; assists surgeons in precise anatomical localization for pedicle screw placement; used in open, minimally invasive, or percutaneous procedures; instruments interface with Medtronic navigation hardware to provide real-time tracking of instrument position relative to patient anatomy; enables surgeon to visualize instrument trajectory on navigation display; facilitates accurate screw placement; improves surgical precision; reduces potential for malposition; instruments are stainless steel; non-sterile; compatible only with specific Spineart implant systems (Romeo2, Perla).

Clinical Evidence

No clinical data. Substantial equivalence supported by engineering analysis and dimensional/tolerance stack-up analysis.

Technological Characteristics

Reusable surgical instruments (screwdrivers, taps, drills) manufactured from stainless steel per ASTM F899. Designed for integration with Medtronic StealthStation (V2.1.0) and NavLock Tracker System. Non-sterile. Mechanical design for manual surgical use; no internal software or electronic sensing components; relies on external navigation system for tracking.

Indications for Use

Indicated for use during spinal surgery for preparation and placement of Spineart screws in open or minimally invasive procedures; intended for use with Medtronic StealthStation System for stereotactic surgery where reference to rigid anatomical structures (long bone or vertebra) is identified via CT, MR, fluoroscopy, or digitized landmarks.

Regulatory Classification

Identification

A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.

Predicate Devices

• SPINEART Navigation Instrument System (K183630)
• SPINEART Navigation Instrument System (K210472)

Reference Devices

• Medtronic StealthStation System (V2.1.0)
• Medtronic NavLock Tracker System

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the U.S. Food & Drug Administration. The Department of Health & Human Services logo is on the left and features a stylized human figure. The FDA logo is on the right and includes the agency's acronym in a blue square, followed by the full name "U.S. Food & Drug Administration" in blue text.

August 7, 2024

Spineart SA Estelle Lefeuvre Regulatory & Market Access Manager Chemin du Pré-Fleuri 3 Plan-les-Ouates, 1228 Switzerland

Re: K241644

Trade/Device Name: SPINEART Navigation Instrument System Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: OLO Dated: June 5, 2024 Received: June 7, 2024

Dear Estelle Lefeuvre:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

{1}------------------------------------------------

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

> Sincerely, Shumaya Ali -S

Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health

{2}------------------------------------------------

### Indications for Use

Submission Number (if known)

K241644

Device Name

SPINEART Navigation Instrument System

Indications for Use (Describe)

The Spineart Navigation Instrument System reusable instruments are intended to be used during the preparation and placement of Spineart screws during spinal surgery to assist the surgeon in precisely locating anatomical structures in either open or minimally invasive procedures. The Spineart Navigation Instrument System reusable instruments are specifically designed for use with the Medtronic StealthStation System, which is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as a long bone or vertebra, can be identified relative to a CT or MR based model, fluoroscopy images, or digitized landmarks for the anatomy.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# Special 510k SPINEART Navigation Instrument System

Image /page/3/Picture/1 description: The image shows a black silhouette of a butterfly. The butterfly's wings are stylized and appear to be overlapping. The wings are rounded and elongated, giving the butterfly a modern and abstract look. The background is plain white, which makes the black butterfly stand out.

## 510(k) SUMMARY

| 510k | Special |
|-----------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Basis for submission | New devices |
| Submitted by | SPINEART SA |
| | 3 Chemin du Pré Fleuri |
| | 1228 Plan-les-Ouates |
| | SWITZERLAND |
| Contacts | Estelle LEFEUVRE, Regulatory & Market Access Manager |
| | Phone : [phone] Fax : [phone] |
| | Mail : [e-mail] |
| | Regulatory contact : Estelle LEFEUVRE ([e-mail]) |
| Date Prepared | June 5th, 2024 |
| Common Name | Orthopedic Stereotaxic Instrument |
| Trade Name | SPINEART Navigation Instrument System |
| Classification Name | Orthopedic Stereotaxic Instrument |
| Class | II |
| Product Code | OLO |
| CFR section | 882.4560 |
| Device panel | Orthopedic |
| Legally marketed<br>predicate devices | Primary predicate: SPINEART Navigation Instrument System<br>manufactured by SPINEART (K183630, K210472) |
| Indications for use | The SPINEART® Navigation Instrument System reusable instruments |
| | are indicated to be used during the preparation and placement of |
| | Spineart screws during spinal surgery to assist the surgeon in precisely |
| | locating anatomical structures in either open or minimally invasive |
| | procedures. The SPINEART® Navigation Instrument System reusable |
| | instruments are specifically designed for use with the Medtronic |
| | StealthStation® System, which is indicated for any medical condition in |
| | which the use of stereotactic surgery may be appropriate, and |
| | where reference to a rigid anatomical structure, such as a long bone or |
| | vertebra, can be identified relative to a CT or MR based model, |
| | fluoroscopy images, or digitized landmarks for the anatomy. |
| Description of the device | The SPINEART® Navigation Instrument System reusable instruments are surgical instruments for use with the Medtronic StealthStation® Navigation System to assist surgeons in precisely locating anatomical structures in either open, minimally invasive, or percutaneous procedures for preparation and placement of pedicle screw system implants.<br><br>The SPINEART® Navigation system includes the following instruments dedicated to screw placement: Screwdrivers, Taps, Drills.<br>The SPINEART® Navigation Instrument System is to be used with the following Spineart Systems:<br>RomeoⓇ2 Romeo®2 MIS PerlaⓇ Perla® TL Perla® TL MIS All instruments are made of stainless steel per ASTM F899. All instruments are reusable instruments provided non sterile.<br><br>The SPINEART® Navigation Instrument System instruments are not compatible with implants from other manufacturers.<br><br>The SPINEART® Navigation Instrument System are designed for use only with Medtronic StealthStation® System (V2.1.0) and the Medtronic NavLock® Tracker System. |
| Technological characteristics compared to the predicate devices | The subject product line extension of the SPINEART® Navigation Instrument System (K183630, K210472) consists of addition of drills and screwdrivers for the Perla TL Posterior Osteosynthesis System and Perla Posterior Occipito-cervico-thoracic Fixation System.<br><br>As was established in this submission, the SPINEART® Navigation added instruments are substantially equivalent and have the same technological characteristics to predicate devices in areas including indications for use, function, material composition, design, range of sizes and accuracy performance. Verification and validation activities conducted on the added navigated instruments demonstrate that these navigated instruments are suitable to be used with the Medtronic StealthStation® System (V2.1.0) and the Medtronic NavLock® Tracker System when implanting screws part of the Perla TL Posterior Osteosynthesis System and Perla Posterior Occipito-cervico-thoracic Fixation System. |
| Discussion of Testing | Addition of navigated instruments to SPINEART® Navigation Instrument System (K183630, K210472) does not require testing. An Engineering Analysis has been submitted to support substantial equivalence. |
| Conclusion | Based on the design features, technological characteristics, feature comparisons, indications for use, and dimensional and tolerance stack-up analysis, the added SPINEART® Navigation Instruments have demonstrated substantial equivalence to the identified predicate devices. |

{4}------------------------------------------------